We found that among CD8+ T cell subsets, Compared with healthy controls and HBV-LC patients, TEMRA was significantly increased in PBMCs of HBV-HCC patients, which is consistent with previous findings (38), which may be related to the decreased recruitment of TEMRA to tumor sites. Here, CD8A is linked to hepatocellular carcinoma.